A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2-negative metastatic breast cancer,Thoracic Cancer - X-MOL
Camrelizumab and metronomic capecitabine for patients with treatment-refractory solid tumors (McCREST trial) | Future Oncology
Metronomic capecitabine maintenance extends DFS in triple-negative breast cancer
Metronomic capecitabine inhibits liver transplant rejection in rats by triggering recipients' T cell ferroptosis
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
![PDF] Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/957fa2625a87315f5d56f5911f5b8b269f747b86/6-Table2-1.png "PDF] Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future? | Semantic Scholar")
PDF] Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future? | Semantic Scholar
Frontiers | Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
Metronomic capecitabine showed no significant myelosuppression. A and... | Download Scientific Diagram
Frontiers | Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
Possible immunosuppressive mechanisms of metronomic capecitabine on T... | Download Scientific Diagram
PDF) Metronomic capecitabine as maintenance treatment after first line induction with XELOX for metastatic colorectal cancer patients
JCM | Free Full-Text | Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer—A Retrospective Analysis of Consecutive Patients Data
PDF) Metronomic Capecitabine in Advanced Hepatocellular Carcinoma Patients: A Phase II Study | Rita Golfieri and Franco Trevisani - Academia.edu
Cancers | Free Full-Text | Metronomic Chemotherapy
JCI Insight - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
JCI Insight - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
Elderly Woman with Triple-negative Metastatic Breast Cancer Successfully Treated with Metronomic Capecitabine | Anticancer Research
Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis
A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer | Trials | Full Text
Clinical overview of metronomic chemotherapy in breast cancer | Nature Reviews Clinical Oncology
PDF) Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients
Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study – topic of research paper in Clinical
